TNF Sarcoidosis (Tumor Necrosis Factor) | Medical Algorithm

Are you evaluating a patient who is being treated with a TNF alpha blocking agent?

Yes

Did the patient have evidence of sarcoidosis prior to starting the TNF alpha blocking agent therapy?

Yes

Has the patient developed systemic symptoms?

Yes

Has the patient developed non-caseating granulomas in lungs, lymph nodes or other sites?

Yes

Are cultures of the granulomas are negative for myocobacteria, fungi and bacteria?

Yes

Have the granulomas regressed on discontinuing the TNF alpha blocking agent therapy?

Yes

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Number of findings seen in drug-induced sarcoidosis associated with TNF alpha blocking agents

Should the diagnosis of TNF alpha blocking agent-induced sarcoidosis be considered in this patient?

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- Prognostic Factors for a Patient with Sarcoidosis
Criteria For Diagnosis
- Acute Sarcoid Myositis (Acute Sarcoid Myopathy)
Severity, Prognosis, Stage
Complications
- Acute Sarcoid Myositis (Acute Sarcoid Myopathy)

Therapy

Selection
- Prognostic Factors for a Patient with Sarcoidosis

Monitoring

Response To Therapy
- Sarcoidosis | Pediatric Patient | Methotrexate Response Criteria
Disease Progression
- Criteria of Mana for Disease Activity in Sarcoidosis
- Systemic Sarcoidosis | Acute vs Chronic Clinical Features

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Therapy

Monitoring

Specialty

Objective

ICD-10

Sarcoidosis Following Therapy with TNF alpha Blocking Agent

Purpose: To evaluate a patient for sarcoidosis as a complication of tumor necrosis factor (TNF) alpha blocking therapy.

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Therapy

Monitoring

Specialty

Objective

ICD-10